Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Florida
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Florida
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Florida.
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- University of Florida, Gainsville
- John Hopkins All Children's Hospital, St. Petersburg
RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942A Registry for People With T-cell Lymphoma
- University of Miami (Data Collection Only), Miami
- Moffitt Cancer Center (Data Collection Only), Tampa
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.